United States Pharmaceuticals

Orthovita Inc (VITA)

Track

Ticker: VITA Exchange: NMQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
BROADBENT NANCY C Senior VP and CFO Officer
Transaction date
Purchase
Price
128.41
Quantity 28,738 -3.3%
Value US$2,371,827
BROADBENT NANCY C Senior VP and CFO Officer
Transaction date
Purchase
Price
222.74
Quantity 52,821 +3.4%
Value US$296,532
BROADBENT NANCY C Senior VP and CFO Officer
Transaction date
Purchase
Price
125.23
Quantity 61,375 -45.9%
Value US$24,664
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.37
Quantity 11,372 +0.1%
Value US$26,994
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.28
Quantity 1,500 +0.0%
Value US$3,416
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.27
Quantity 8,900 +0.1%
Value US$20,178
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.24
Quantity 15,000 +0.2%
Value US$33,574
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.28
Quantity 2,500 +0.0%
Value US$5,700
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.25
Quantity 13,800 +0.1%
Value US$31,116
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.28
Quantity 5,670 +0.1%
Value US$12,909
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.06
Quantity 35,000 +0.4%
Value US$72,152
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.25
Quantity 25,000 +0.3%
Value US$56,320
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.29
Quantity 10,000 +0.1%
Value US$22,913
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.36
Quantity 10,000 +0.1%
Value US$23,597
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.31
Quantity 15,000 +0.2%
Value US$34,684
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.37
Quantity 8,500 +0.1%
Value US$20,154
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
Transaction date
Purchase
Price
2.38
Quantity 1,200 +0.0%
Value US$2,856
Jennings William Patrick Jr VP Controller
Transaction date
Purchase
Price
2.30
Quantity 500 +50.0%
Value US$1,150
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.14
Quantity 1,953 +inf%
Value US$4,179
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.15
Quantity 3,100 +inf%
Value US$6,665
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.16
Quantity 4,199 +inf%
Value US$9,070
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.17
Quantity 748 +inf%
Value US$1,623
Barry Scott Non-Executive Director
Transaction date
Purchase
Price
1.96
Quantity 3,750 +inf%
Value US$7,350
Jennings William Patrick Jr VP Controller
Transaction date
Purchase
Price
1.99
Quantity 1,000 +inf%
Value US$1,990
KOBLISH ANTONY President & CEO Executive Director
Transaction date
Purchase
Price
2.49
Quantity 5,000 +inf%
Value US$12,471
Smith Christopher H Senior VP-US Sales Officer
Transaction date
Purchase
Price
2.52
Quantity 2,000 +inf%
Value US$5,038
PERSENAIRE MAARTEN Chief Medical Officer Officer
Transaction date
Purchase
Price
2.52
Quantity 2,000 +inf%
Value US$5,040
Smith Christopher H Senior VP-US Sales Officer
Transaction date
Purchase
Price
2.80
Quantity 1,500 +inf%
Value US$4,200
Smith Christopher H Senior VP-US Sales Officer
Transaction date
Purchase
Price
2.79
Quantity 1,500 +inf%
Value US$4,185
Smith Christopher H Senior VP-US Sales Officer
Transaction date
Purchase
Price
2.88
Quantity 1,400 +inf%
Value US$4,032
Smith Christopher H Senior VP-US Sales Officer
Transaction date
Purchase
Price
2.87
Quantity 451 +inf%
Value US$1,294
Smith Christopher H Senior VP-US Sales Officer
Transaction date
Purchase
Price
2.86
Quantity 3,600 +inf%
Value US$10,296
FITZGERALD DAVID Non-Executive Director
Transaction date
Purchase
Price
2.87
Quantity 5,000 +inf%
Value US$14,350
KOBLISH ANTONY President & CEO Executive Director
Transaction date
Purchase
Price
2.94
Quantity 6,060 +inf%
Value US$17,816
KOBLISH ANTONY President & CEO Executive Director
Transaction date
Purchase
Price
2.93
Quantity 2,800 +inf%
Value US$8,204
KOBLISH ANTONY President & CEO Executive Director
Transaction date
Purchase
Price
2.92
Quantity 2,400 +inf%
Value US$7,008
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.92
Quantity 5,000 +inf%
Value US$14,600
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.91
Quantity 2,500 +inf%
Value US$7,275
KOBLISH ANTONY President & CEO Executive Director
Transaction date
Purchase
Price
2.90
Quantity 240 +inf%
Value US$696
Touhey Paul Non-Executive Director
Transaction date
Purchase
Price
2.90
Quantity 2,500 +inf%
Value US$7,250
Pavucek Albert J Jr Chief Financial Officer Officer
Transaction date
Purchase
Price
2.89
Quantity 5,000 +inf%
Value US$14,450
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-11-09 2009-11-09 B Purchase BROADBENT NANCY C

Senior VP and CFO

Officer
28,738 -3.3%
128.41
US$2,371,827 		28,738 -3.3% 128.41 US$2,371,827
2009-05-27 2009-05-27 B Purchase BROADBENT NANCY C

Senior VP and CFO

Officer
52,821 +3.4%
222.74
US$296,532 		52,821 +3.4% 222.74 US$296,532
2009-05-27 2009-05-26 B Purchase BROADBENT NANCY C

Senior VP and CFO

Officer
61,375 -45.9%
125.23
US$24,664 		61,375 -45.9% 125.23 US$24,664
2008-11-21 2008-11-20 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
11,372 +0.1%
2.37
US$26,994 		11,372 +0.1% 2.37 US$26,994
2008-10-30 2008-10-28 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
1,500 +0.0%
2.28
US$3,416 		1,500 +0.0% 2.28 US$3,416
2008-10-28 2008-10-27 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
8,900 +0.1%
2.27
US$20,178 		8,900 +0.1% 2.27 US$20,178
2008-10-28 2008-10-24 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
15,000 +0.2%
2.24
US$33,574 		15,000 +0.2% 2.24 US$33,574
2008-10-24 2008-10-22 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
2,500 +0.0%
2.28
US$5,700 		2,500 +0.0% 2.28 US$5,700
2008-10-20 2008-10-16 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
13,800 +0.1%
2.25
US$31,116 		13,800 +0.1% 2.25 US$31,116
2008-10-15 2008-10-13 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
5,670 +0.1%
2.28
US$12,909 		5,670 +0.1% 2.28 US$12,909
2008-10-15 2008-10-10 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
35,000 +0.4%
2.06
US$72,152 		35,000 +0.4% 2.06 US$72,152
2008-10-10 2008-10-09 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
25,000 +0.3%
2.25
US$56,320 		25,000 +0.3% 2.25 US$56,320
2008-10-10 2008-10-08 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
10,000 +0.1%
2.29
US$22,913 		10,000 +0.1% 2.29 US$22,913
2008-10-08 2008-10-07 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
10,000 +0.1%
2.36
US$23,597 		10,000 +0.1% 2.36 US$23,597
2008-10-08 2008-10-06 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
15,000 +0.2%
2.31
US$34,684 		15,000 +0.2% 2.31 US$34,684
2008-10-08 2008-10-03 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
8,500 +0.1%
2.37
US$20,154 		8,500 +0.1% 2.37 US$20,154
2008-10-08 2008-10-02 B Purchase ESSEX WOODLANDS HEALTH VENTURES FUND VII LP Large shareholder
1,200 +0.0%
2.38
US$2,856 		1,200 +0.0% 2.38 US$2,856
2008-05-29 2008-05-29 B Purchase Jennings William Patrick Jr

VP Controller
500 +50.0%
2.30
US$1,150 		500 +50.0% 2.30 US$1,150
2008-05-15 2008-05-15 B Purchase Touhey Paul Non-Executive Director
1,953 +inf%
2.14
US$4,179 		1,953 +inf% 2.14 US$4,179
2008-05-15 2008-05-15 B Purchase Touhey Paul Non-Executive Director
3,100 +inf%
2.15
US$6,665 		3,100 +inf% 2.15 US$6,665
2008-05-15 2008-05-15 B Purchase Touhey Paul Non-Executive Director
4,199 +inf%
2.16
US$9,070 		4,199 +inf% 2.16 US$9,070
2008-05-15 2008-05-15 B Purchase Touhey Paul Non-Executive Director
748 +inf%
2.17
US$1,623 		748 +inf% 2.17 US$1,623
2008-05-12 2008-05-12 B Purchase Barry Scott Non-Executive Director
3,750 +inf%
1.96
US$7,350 		3,750 +inf% 1.96 US$7,350
2008-05-12 2008-05-12 B Purchase Jennings William Patrick Jr

VP Controller
1,000 +inf%
1.99
US$1,990 		1,000 +inf% 1.99 US$1,990
2007-09-17 2007-09-14 B Purchase KOBLISH ANTONY

President & CEO

Executive Director
5,000 +inf%
2.49
US$12,471 		5,000 +inf% 2.49 US$12,471
2007-09-17 2007-09-14 B Purchase Smith Christopher H

Senior VP-US Sales

Officer
2,000 +inf%
2.52
US$5,038 		2,000 +inf% 2.52 US$5,038
2007-09-17 2007-09-14 B Purchase PERSENAIRE MAARTEN

Chief Medical Officer

Officer
2,000 +inf%
2.52
US$5,040 		2,000 +inf% 2.52 US$5,040
2007-05-31 2007-05-30 B Purchase Smith Christopher H

Senior VP-US Sales

Officer
1,500 +inf%
2.80
US$4,200 		1,500 +inf% 2.80 US$4,200
2007-05-31 2007-05-30 B Purchase Smith Christopher H

Senior VP-US Sales

Officer
1,500 +inf%
2.79
US$4,185 		1,500 +inf% 2.79 US$4,185
2007-05-29 2007-05-25 B Purchase Smith Christopher H

Senior VP-US Sales

Officer
1,400 +inf%
2.88
US$4,032 		1,400 +inf% 2.88 US$4,032
2007-05-29 2007-05-25 B Purchase Smith Christopher H

Senior VP-US Sales

Officer
451 +inf%
2.87
US$1,294 		451 +inf% 2.87 US$1,294
2007-05-29 2007-05-25 B Purchase Smith Christopher H

Senior VP-US Sales

Officer
3,600 +inf%
2.86
US$10,296 		3,600 +inf% 2.86 US$10,296
2007-05-24 2007-05-23 B Purchase FITZGERALD DAVID Non-Executive Director
5,000 +inf%
2.87
US$14,350 		5,000 +inf% 2.87 US$14,350
2007-05-10 2007-05-10 B Purchase KOBLISH ANTONY

President & CEO

Executive Director
6,060 +inf%
2.94
US$17,816 		6,060 +inf% 2.94 US$17,816
2007-05-10 2007-05-10 B Purchase KOBLISH ANTONY

President & CEO

Executive Director
2,800 +inf%
2.93
US$8,204 		2,800 +inf% 2.93 US$8,204
2007-05-10 2007-05-10 B Purchase KOBLISH ANTONY

President & CEO

Executive Director
2,400 +inf%
2.92
US$7,008 		2,400 +inf% 2.92 US$7,008
2007-05-10 2007-05-10 B Purchase Touhey Paul Non-Executive Director
5,000 +inf%
2.92
US$14,600 		5,000 +inf% 2.92 US$14,600
2007-05-10 2007-05-10 B Purchase Touhey Paul Non-Executive Director
2,500 +inf%
2.91
US$7,275 		2,500 +inf% 2.91 US$7,275
2007-05-10 2007-05-10 B Purchase KOBLISH ANTONY

President & CEO

Executive Director
240 +inf%
2.90
US$696 		240 +inf% 2.90 US$696
2007-05-10 2007-05-10 B Purchase Touhey Paul Non-Executive Director
2,500 +inf%
2.90
US$7,250 		2,500 +inf% 2.90 US$7,250
2007-05-10 2007-05-10 B Purchase Pavucek Albert J Jr

Chief Financial Officer

Officer
5,000 +inf%
2.89
US$14,450 		5,000 +inf% 2.89 US$14,450
Explore more

More insider trading research around Orthovita Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America